Telepharmacy as a promising direction for the development of pharmaceutical care in the context of digital transformation
- Authors: Prosvirkin G.A.1, Dorofeeva V.V.1
- Affiliations:
- Peoples’ Friendship University of Russia, Moscow, Russia
- Issue: No 1 (2023)
- Pages: 81-85
- Section: Articles
- URL: https://remedium-journal.ru/journal/article/view/1584
- DOI: https://doi.org/10.32687/1561-5936-2023-27-1-81-85
- Cite item
Abstract
About the authors
Georgiy A. Prosvirkin
Peoples’ Friendship University of Russia, Moscow, Russia
Email: rudn.ru, https://orcid.org/0000-0001-5598-6055
Valeria V. Dorofeeva
Peoples’ Friendship University of Russia, Moscow, Russia
Email: 002
References
- Angaran D. M. Telemedicine and telepharmacy: сurrent status and future implications. Am. J. Health Syst. Pharmacy. 1999; 56(14): 1405—1426. doi: 10.1093/ajhp/56.14.1405; 2. Al-Arkee S., Manson J., Lane D. A. et al. Mobile Apps to improve medication adherence in cardiovascular disease: systematic review and meta-analysis. J. Med. Internet Res. 2021; 23(5):е24190. doi: 10.2196/24190; 3. Tabi K., Randhawa A. S., Choi F. et al. Mobile Apps for medication management: review and analysis. JMIR Mhealth Uhealth. 2019; 7(9): е13608. doi: 10.2196/13608; 4. Le T., Toscani M., Colaizzi J. Telepharmacy: a new paradigm for our profession. J. Pharm. Pract. 2018; 33(2): 176—182. doi: 10.1177/0897190018791060; 5. Li H., Zheng S., Li D. The establishment and practice of pharmacy care service based on internet social media: telemedicine in response to the COVID-19 pandemic. Front. Pharmacol. 2021; 12: 707442. doi: 10.3389/fphar.2021.707442; 6. Asseri A. A., Manna M. M., Yasin I. M. et al. Implementation and evaluation of telepharmacy during COVID-19 pandemic in an academic medical city in the Kingdom of Saudi Arabia: paving the way for telepharmacy. World J. Adv. Res. Rev. 2020; 7(2): 218—226.; 7. Mishchenko M., Ponomareva A., Konyshkina T., Mishchenko E. Analysis of the impact of the COVID-19 pandemic on the pharmaceutical industry. Eurasian Scientific Association. 2020; (12—3): 201—204. (In Russ.); 8. Margusino-Framiñán L., Illarro-Uranga A., Lorenzo-Lorenzo K. et al. Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy. Farm. Hosp. 2020; 44(7): 61—65. doi: 10.7399/fh.11498; 9. Yemm K. E., Arnall J. R., Cowgill N. A. Necessity of pharmacist-driven nonprescription telehealth consult services in the era of COVID-19. Am. J. Health Syst. Pharm. 2020; 77(15): 1188. doi: 10.1093/ajhp/zxaa162; 10. Agnew J., Alicehajic‐Becic D., Barnett N. et al. Optimising remote consultations for older people during COVID‐19. Prescriber. 2021; 32(3): 9—14.; 11. Li H., Zheng S., Liu F. et al. Fighting against COVID-19: innovative strategies for clinical pharmacists. Res. Social Adm. Pharm. 2021; 17(1): 1813—1818. doi: 10.1016/j.sapharm.2020.04.003; 12. Baldoni S., Amenta F., Ricci G. Telepharmacy services: present status and future perspectives: a review. Medicina (Kaunas). 2019; 55(7): 327.; 13. Taylor A. M., Bingham J., Schussel K. et al. Integrating innovative telehealth solutions into an interprofessional team-delivered chronic care management pilot program. J. Manag. Care Spec. Pharm. 2018; 24(8): 813—818. doi: 10.18553/jmcp.2018.24.8.813; 14. Centers for disease control and prevention. Community pharmacists and medication therapy management, 2021. URL: https://www.cdc.gov/dhdsp/pubs/guides/best-practices/pharmacist-mtm.htm (дата обращения: 24.06.2022).